Scientific evidences about this steviosíde in mellitus Diabetes type 2 control: a review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/22051 |
Resumo: | The aim of the present article was to search for scientific evidence to evaluate the function and action of stevioside in patients with mellitus diabetes type 2. This work is an integrative literature review, the sources were linked in the following databases: (Scielo), (PubMed), LILACS and Academic Google. It was chosen some selection for the present sample and criteria for original articles indexed from 2017 to 2021 were established. The choice of this period presented results to the criterion of temporality, in which the five-year selected period was considered, as these are more current publications, in English and Portuguese in the studies analyzed, it was evidenced that stevioside is a glycosidic compound with high sweetness, low caloric value, including the interaction with glimeripedine and metformin, which enhances glycemic reduction through antioxidant actions and improves the lipid profile. It highlighted the action in reducing glucose and total cholesterol levels, preventing oxidative damage and improving liver and kidney function, as well as reducing damage to internal organs through removing tissue collagen and contributing to normal cardiac functioning. It also demonstrates positive results in satiety, contributing to a delay in gastric emptying and being useful in the treatment of obesity, working in the inhibition of glucose absorption. According this database, it is concluded that stevioside has preventive and metabolic function, besides to promote pre-clinical and experimental studies, culminating in non-caloric, anti-diabetic and anti-hyperglycemic effects, with sensory, therapeutic and nutritional quality. |
id |
UNIFEI_c6635ce2691c5d41b25da9c44fa76295 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/22051 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Scientific evidences about this steviosíde in mellitus Diabetes type 2 control: a reviewEvidencia científica sobre el esteviósido en el control de la Diabetes mellitus tipo 2: una revisiónEvidências científicas acerca do esteviosídeo no controle do Diabetes mellitus tipo 2: uma revisão Diabetes mellitus type IISteviaSteviosídeGlycosides.Diabetes mellitus tipo2SteviaEsteviósidoGlucósidos.EstéviaEsteviosídeoDiabetes mellitus tipo 2Glicosídeos.The aim of the present article was to search for scientific evidence to evaluate the function and action of stevioside in patients with mellitus diabetes type 2. This work is an integrative literature review, the sources were linked in the following databases: (Scielo), (PubMed), LILACS and Academic Google. It was chosen some selection for the present sample and criteria for original articles indexed from 2017 to 2021 were established. The choice of this period presented results to the criterion of temporality, in which the five-year selected period was considered, as these are more current publications, in English and Portuguese in the studies analyzed, it was evidenced that stevioside is a glycosidic compound with high sweetness, low caloric value, including the interaction with glimeripedine and metformin, which enhances glycemic reduction through antioxidant actions and improves the lipid profile. It highlighted the action in reducing glucose and total cholesterol levels, preventing oxidative damage and improving liver and kidney function, as well as reducing damage to internal organs through removing tissue collagen and contributing to normal cardiac functioning. It also demonstrates positive results in satiety, contributing to a delay in gastric emptying and being useful in the treatment of obesity, working in the inhibition of glucose absorption. According this database, it is concluded that stevioside has preventive and metabolic function, besides to promote pre-clinical and experimental studies, culminating in non-caloric, anti-diabetic and anti-hyperglycemic effects, with sensory, therapeutic and nutritional quality.El objetivo de este estudio fue buscar evidencia científica para evaluar el uso y la acción del esteviósido en pacientes con diabetes mellitus tipo 2. Esta es una revisión de literatura integradora, las fuentes de búsqueda se encontraban en las siguientes bases de datos: (Scielo), (PubMed), LILACS y Academic Google. Para la selección de la muestra se establecieron criterios para artículos originales indexados de 2017 a 2021. La elección de este período cumplió con el criterio de temporalidad, en el que se consideró el corte quinquenal, por tratarse de publicaciones más actuales, en inglés y portugués. En los estudios examinados, se evidenció que el esteviósido es un compuesto glucosídico con alto dulzor, bajo valor calórico, incluyendo la interacción con glimeripedina y metformina, que potencia la reducción glucémica mediante acciones antioxidantes y mejora el perfil lipídico. Su acción también se destaca en la reducción de los niveles de glucosa y colesterol total, previniendo el daño oxidativo y mejorando la función hepática y renal, además de reducir el daño a los órganos internos al eliminar el colágeno tisular y contribuir al funcionamiento cardíaco normal. También demuestra resultados positivos en saciedad, contribuyendo a un retraso en el vaciamiento gástrico y siendo útil en el tratamiento de la obesidad, actuando en la inhibición de la absorción de glucosa. Así, se concluye que el esteviósido tiene acción preventiva y metabólica, además de promover estudios preclínicos y experimentales, culminando en efectos no calóricos, antidiabéticos y antihiperglucémicos, con calidad sensorial, terapéutica y nutricional.O objetivo desse estudo foi fazer uma busca de evidências científicas para avaliar o uso e ação do esteviosídeo em pacientes com diabetes mellitus tipo2. Trata-se de uma de revisão integrativa da literatura, as fontes de busca foram às bases de dados: Scielo, PubMed, LILACS e Google Acadêmico. Para a seleção da amostra foi estabelecido critérios de artigos originais indexados de 2017 a 2021, a escolha deste período atendeu ao critério de temporalidade, em que foi considerado o recorte de cinco anos, por se tratar de publicações mais atuais, na língua inglesa e portuguesa. Nos estudos examinados evidenciou-se que o esteviosídeo se apresenta como um composto glicosídico com elevada doçura, baixo valor calórico, inclui a interação à glimeripedina e metformina, o que potencializa a redução glicêmica por meio de ações antioxidantes e melhora do perfil lipídico. Ressalta-se ainda sua ação na diminuição dos níveis de glicose e colesterol total, prevenção do dano oxidativo e melhora da função hepática e renal, como também reduz os danos dos órgãos internos fazendo a remoção tecidual de colágeno e contribuindo para o funcionamento normal cardíaco. Também demonstra resultados positivos na saciedade contribuindo para retardo do esvaziamento gástrico e sendo útil no tratamento da obesidade atuando na inibição da absorção de glicose. Dessa forma, conclui-se que o esteviosídeo tem ação preventiva e metabólica, além de fomentar estudos pré-clínicos e experimentais, culminando em efeitos não calóricos, antidiabéticos e anti-hiperglicêmicos, apresentando qualidade sensorial, terapêutica e nutricional.Research, Society and Development2021-11-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2205110.33448/rsd-v10i14.22051Research, Society and Development; Vol. 10 No. 14; e331101422051Research, Society and Development; Vol. 10 Núm. 14; e331101422051Research, Society and Development; v. 10 n. 14; e3311014220512525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/22051/19732Copyright (c) 2021 Lílian Pereira e Silva; Keila Cristiane Batista Bezerra; Liejy Agnes dos Santos Raposo Landimhttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSilva, Lílian Pereira e Bezerra, Keila Cristiane Batista Landim, Liejy Agnes dos Santos Raposo 2021-12-04T11:48:39Zoai:ojs.pkp.sfu.ca:article/22051Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:41:19.270786Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Scientific evidences about this steviosíde in mellitus Diabetes type 2 control: a review Evidencia científica sobre el esteviósido en el control de la Diabetes mellitus tipo 2: una revisión Evidências científicas acerca do esteviosídeo no controle do Diabetes mellitus tipo 2: uma revisão |
title |
Scientific evidences about this steviosíde in mellitus Diabetes type 2 control: a review |
spellingShingle |
Scientific evidences about this steviosíde in mellitus Diabetes type 2 control: a review Silva, Lílian Pereira e Diabetes mellitus type II Stevia Steviosíde Glycosides. Diabetes mellitus tipo2 Stevia Esteviósido Glucósidos. Estévia Esteviosídeo Diabetes mellitus tipo 2 Glicosídeos. |
title_short |
Scientific evidences about this steviosíde in mellitus Diabetes type 2 control: a review |
title_full |
Scientific evidences about this steviosíde in mellitus Diabetes type 2 control: a review |
title_fullStr |
Scientific evidences about this steviosíde in mellitus Diabetes type 2 control: a review |
title_full_unstemmed |
Scientific evidences about this steviosíde in mellitus Diabetes type 2 control: a review |
title_sort |
Scientific evidences about this steviosíde in mellitus Diabetes type 2 control: a review |
author |
Silva, Lílian Pereira e |
author_facet |
Silva, Lílian Pereira e Bezerra, Keila Cristiane Batista Landim, Liejy Agnes dos Santos Raposo |
author_role |
author |
author2 |
Bezerra, Keila Cristiane Batista Landim, Liejy Agnes dos Santos Raposo |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Silva, Lílian Pereira e Bezerra, Keila Cristiane Batista Landim, Liejy Agnes dos Santos Raposo |
dc.subject.por.fl_str_mv |
Diabetes mellitus type II Stevia Steviosíde Glycosides. Diabetes mellitus tipo2 Stevia Esteviósido Glucósidos. Estévia Esteviosídeo Diabetes mellitus tipo 2 Glicosídeos. |
topic |
Diabetes mellitus type II Stevia Steviosíde Glycosides. Diabetes mellitus tipo2 Stevia Esteviósido Glucósidos. Estévia Esteviosídeo Diabetes mellitus tipo 2 Glicosídeos. |
description |
The aim of the present article was to search for scientific evidence to evaluate the function and action of stevioside in patients with mellitus diabetes type 2. This work is an integrative literature review, the sources were linked in the following databases: (Scielo), (PubMed), LILACS and Academic Google. It was chosen some selection for the present sample and criteria for original articles indexed from 2017 to 2021 were established. The choice of this period presented results to the criterion of temporality, in which the five-year selected period was considered, as these are more current publications, in English and Portuguese in the studies analyzed, it was evidenced that stevioside is a glycosidic compound with high sweetness, low caloric value, including the interaction with glimeripedine and metformin, which enhances glycemic reduction through antioxidant actions and improves the lipid profile. It highlighted the action in reducing glucose and total cholesterol levels, preventing oxidative damage and improving liver and kidney function, as well as reducing damage to internal organs through removing tissue collagen and contributing to normal cardiac functioning. It also demonstrates positive results in satiety, contributing to a delay in gastric emptying and being useful in the treatment of obesity, working in the inhibition of glucose absorption. According this database, it is concluded that stevioside has preventive and metabolic function, besides to promote pre-clinical and experimental studies, culminating in non-caloric, anti-diabetic and anti-hyperglycemic effects, with sensory, therapeutic and nutritional quality. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-11-03 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/22051 10.33448/rsd-v10i14.22051 |
url |
https://rsdjournal.org/index.php/rsd/article/view/22051 |
identifier_str_mv |
10.33448/rsd-v10i14.22051 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/22051/19732 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 10 No. 14; e331101422051 Research, Society and Development; Vol. 10 Núm. 14; e331101422051 Research, Society and Development; v. 10 n. 14; e331101422051 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052790267183104 |